LifeBond’s surgical sealant gets EU approval, FDA fast-track status

LifeSeal, the no-leak sealant solution for patients who have undergone gastrointestinal (GI) surgery,  is now on the fast track to FDA approval. The product was given the FDA’s Expedited Access Pathway (EAP) designation, and is now eligible for quicker approval consideration, which the company hopes will take place after it begins its new international study which will include sites in the United States and Europe.

To read the full article, click here.

Author: Ethan Goldspiel

Comments are disabled.